Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Depreciation and Depletion (2019 - 2025)

InspireMD's Depreciation and Depletion history spans 10 years, with the latest figure at $143000.0 for Q4 2025.

  • For Q4 2025, Depreciation and Depletion rose 90.67% year-over-year to $143000.0; the TTM value through Dec 2025 reached $476000.0, up 70.0%, while the annual FY2025 figure was $476000.0, 70.0% up from the prior year.
  • Depreciation and Depletion reached $143000.0 in Q4 2025 per NSPR's latest filing, up from $128000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $143000.0 in Q4 2025 to a low of $33000.0 in Q2 2021.
  • Average Depreciation and Depletion over 5 years is $68263.2, with a median of $58000.0 recorded in 2023.
  • Peak YoY movement for Depreciation and Depletion: decreased 19.61% in 2022, then soared 90.67% in 2025.
  • A 5-year view of Depreciation and Depletion shows it stood at $37000.0 in 2021, then surged by 45.95% to $54000.0 in 2022, then rose by 12.96% to $61000.0 in 2023, then rose by 22.95% to $75000.0 in 2024, then soared by 90.67% to $143000.0 in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Depreciation and Depletion are $143000.0 (Q4 2025), $128000.0 (Q3 2025), and $107000.0 (Q2 2025).